Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings
Sponsor: National Healthcare Group Polyclinics
Summary
Primary objective of the study is to determine the extent that offering of self-sampling in addition to clinician-sampling Human Papillomavirus (HPV) DNA testing will increase detection of HPV DNA through an increase in uptake rates of cervical cancer screening as compared to offering clinician-sampling HPV DNA testing alone. The hypothesis is that offering additional self-sampling will increase the detection of high-risk HPV DNA by at least 7.7%.
Key Details
Gender
FEMALE
Age Range
30 Years - 69 Years
Study Type
INTERVENTIONAL
Enrollment
650
Start Date
2024-08-05
Completion Date
2026-12
Last Updated
2025-02-10
Healthy Volunteers
Yes
Conditions
Interventions
Self-sampled HPV DNA testing
Participants will be offered HPV DNA testing done through self-sampling (using self-sampling HPV DNA kits to obtain a mid-vaginal swab)
Clinician-sampled HPV DNA test
Participants will be offered HPV DNA testing through clinician sampling (clinician-sampling (speculum examination by a nurse to obtain a cervical swab)
Locations (1)
National Healthcare Group Polyclinics
Singapore, Singapore, Singapore